Preventing infection-associated cancer: from bench to hillside

J Natl Cancer Inst. 2005 Feb 16;97(4):245-6. doi: 10.1093/jnci/dji059.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Carcinoma, Hepatocellular / epidemiology
  • Carcinoma, Hepatocellular / prevention & control*
  • Carcinoma, Hepatocellular / virology
  • DNA, Viral / isolation & purification
  • Genotype
  • Hepatitis B / complications*
  • Hepatitis B / drug therapy*
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B e Antigens / blood
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology
  • Hepatitis B virus / isolation & purification*
  • Humans
  • Incidence
  • Liver Neoplasms / epidemiology
  • Liver Neoplasms / prevention & control*
  • Liver Neoplasms / virology
  • Male
  • Risk Assessment
  • Risk Factors
  • Taiwan / epidemiology
  • Viral Load

Substances

  • Antiviral Agents
  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens